4 reports

Each warrant will have the right to purchase one-half of one share of its common stock.

  • Ear, Nose, And Throat Medicine
  • Pharmaceutical
  • Therapy
  • United States
  • Soligenix, Inc.

It offers TG## and various candidates for chronic hepatitis B and tuberculosis.

  • Ear, Nose, And Throat Medicine
  • Sexually Transmitted Disease
  • Vaccine
  • United States
  • Advaxis, Inc.
  • VACCINE FOR AUTOIMMUNE DISEASE, CARDIOVASCULAR DISEASE, IMMUNOLOGY, INFECTIOUS DISEASE AND ONCOLOGY - DRUG PROFILE
  • SMALL MOLECULES FOR HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - DRUG PROFILE

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...

  • Cancer
  • Ear, Nose, And Throat Medicine
  • United States
  • Company
  • Product Initiative
  • SMALL MOLECULES FOR HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - DRUG PROFILE

Durvalumab acts as CD## (Programmed Cell Death ##-Ligand ## or PDL-##) inhibitor.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • United States
  • Company
  • Product Initiative